Literature DB >> 12917252

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.

Fiona Walsh1, Joanne Willcock, Sebastian Amyes.   

Abstract

Resistance to macrolides in Streptococcus pneumoniae is usually mediated by methylation of 23S ribosomal RNA, encoded by the erm(B) methylation gene, or by efflux mediated by the mef(A) gene. Changes in the L4 and L22 ribosomal proteins have also been associated with macrolide resistance and reduced telithromycin activity. This study generated in vitro mutants from three parent strains of S. pneumoniae: 02J1175 [mef(A) +], 02J1095 [erm(B) +] and NCTC 13593 (macrolide susceptible). The erm(B) and the erm(B) upstream region, the mef(A) genes and the mef(A) upstream and downstream regions, the 23S rRNA genes encoding domains II and V and the L4 and L22 genes of the telithromycin-resistant strains were all amplified by PCR and all, except the mef(A) upstream and downstream regions, were sequenced. No changes were present in any of the genes of the mef(A) + mutants. No changes were found in the erm(B) genes, the 23S rRNA genes or the L4 protein genes of the erm(B) + mutants. However, a Lys-94 to Gln-94 amino acid mutation did occur in a mutant derived from erm(B) + with a telithromycin MIC of >32 mg/L. A 210 base pair deletion in the erm(B) upstream region was also present in this strain. We believe this is the first incidence of a Lys-94 to Gln-94 change in L22 associated with telithromycin resistance and also the first time that such a large deletion in the erm(B) upstream region has been identified in S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917252     DOI: 10.1093/jac/dkg348

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Nicole Wolter; Anthony M Smith; Donald E Low; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

2.  Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.

Authors:  Adnan Al-Lahham; Peter C Appelbaum; Mark van der Linden; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

3.  Emergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.

Authors:  Diego Faccone; Patricia Andres; Marcelo Galas; Marta Tokumoto; Adriana Rosato; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.

Authors:  Hiroyuki Sugiyama; Ippei Yoshida; Mayumi Ueki; Katsuhiko Tanabe; Akira Manaka; Keiichi Hiramatsu
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

5.  Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.

Authors:  Vlatka Matic; Klaudia Kosowska; Bulent Bozdogan; Linda M Kelly; Kathy Smith; Lois M Ednie; Gengrong Lin; Kim L Credito; Catherine L Clark; Pamela McGhee; Glenn A Pankuch; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.

Authors:  Rita Berisio; Natascia Corti; Peter Pfister; Ada Yonath; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2006-08-21       Impact factor: 5.191

Review 7.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

8.  In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002.

Authors:  Jeff Powis; Allison McGeer; Karen Green; Otto Vanderkooi; Karl Weiss; George Zhanel; Tony Mazzulli; Magdalena Kuhn; Deirdre Church; Ross Davidson; Kevin Forward; Daryl Hoban; Andrew Simor; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.

Authors:  Akiko Takaya; Yoshiharu Sato; Tatsuma Shoji; Tomoko Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

10.  Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.

Authors:  Lotta Siira; Merja Rantala; Jari Jalava; Antti J Hakanen; Pentti Huovinen; Tarja Kaijalainen; Outi Lyytikäinen; Anni Virolainen
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.